GPs ’ views on the use of depression screening and GP-targeted feedback: a qualitative study

ConclusionAddressing GPs ’ needs is essential when implementing depression screening tools in clinical practice. To overcome prejudices and enhance the efficacy of screening, further education for GPs on the purpose and application on depression screening may be needed. Standardized GP-targeted feedback in combination wit h depression screening could be the missing link to improve the detection of depression in primary care.
Source: Quality of Life Research - Category: Health Management Source Type: research

Related Links:

Hello, I am currently a sophomore pre-veterinary student and I am struggling. I did pretty well for my first year of undergrad last year finishing with a 3.57 GPA. This semester has been a different story however. In the first month of school I had an unexpected surgical procedure and I went into a big depression after. Long story short, I had to withdraw from my organic chemistry class and I am possibly going to fail two classes (philosophy and a communications class). In addition, I am... Read more
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Pre-Veterinary Source Type: forums
Conclusions Patients with CRC who had higher levels of protective factors had higher levels of resilience. This study provides new information on the role of depressive symptoms as a partial mediator between protective factors and resilience. Implications for Practice Oncology nurses need to evaluate for depressive symptoms as well as protective factors and resilience in patients with CRC.
Source: Cancer Nursing - Category: Nursing Tags: ARTICLES: ONLINE ONLY Source Type: research
The objective of this study is to determine the effects of the MBLRP on anxiety and depressive symptoms in cancer patients undergoing chemotherapy. Methods A randomized controlled trial with repeated measures was adopted. Eighty-four cancer patients undergoing chemotherapy were recruited from a general hospital in Fujian, China. Participants were randomly assigned to an experimental group (n = 40) or a control group (n = 44). The participants in the experimental group received the MBLRP plus routine care. The participants in the control group received routine care. Outcomes were measured at baseline, on the second d...
Source: Cancer Nursing - Category: Nursing Tags: ARTICLES: ONLINE ONLY Source Type: research
Conclusions Quality of life was lower in Korean BCS than comparable studies in the United States, although participants received care at a premiere medical center. Depressive symptoms and anxiety were common and did not taper off over the 5 years after diagnosis, unlike BCS elsewhere. Korean survivors experienced significant physical fatigability, much higher than reported in a US study of mixed male and female cancer survivors. Overwork was not a significant predictor of QOL, although 30% of employed women reported working 45 to 90 hours weekly. Implications for Practice Findings demonstrate the importance of c...
Source: Cancer Nursing - Category: Nursing Tags: ARTICLES: ONLINE ONLY Source Type: research
Conclusions This is the first review of genetic variations related to differences in levels of depressive symptoms among breast cancer patients. Genetic polymorphisms in inflammatory, neuronal system, and signal transduction pathways can influence the susceptibility. However, more research regarding this topic is needed to further clarify genetic risk factors. Implications for Practice Healthcare providers may determine patients at higher risk of developing depression and symptom outcomes if genetic biomarkers with good sensitivity/specificity are provided. This knowledge can potentially help the development of ...
Source: Cancer Nursing - Category: Nursing Tags: ARTICLES: ONLINE ONLY Source Type: research
Psychedelic therapy focused on psilocybin has received new interest as a potential treatment against anxiety, depression and other mental illness.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Source: Risk Management and Healthcare Policy - Category: Health Management Tags: Risk Management and Healthcare Policy Source Type: research
Condition:   Major Depressive Disorder Interventions:   Dietary Supplement: Escitalopram+Sulforaphane;   Device: Escitalopram+rTMS;   Drug: Escitalopram Sponsor:   Shanghai Mental Health Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Depressive Disorder, Major;   Depression;   Depression, Unipolar;   Depressive Disorder Interventions:   Device: Slow-wave enhancement;   Device: Sham device Sponsor:   University of Pennsylvania Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Discussion Forum Sponsors:   University of Regina;   Government of Canada Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Depression | Education | Germany Health | Health Management | Men | Primary Care | Study | Universities & Medical Training